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CONTEXT:  Bariatric  surgery  has  beneﬁcial  effects  on  obesity  and  associated  comorbidities  such  as
glycaemic  control  in type  2  diabetes,  dyslipidaemia,  hypertension,  and  renal  and  hepatic  function.  Nev-
ertheless,  this  surgery  is  not  free  of complications  and  possible  side  effects  due  to restrictive  and/or
malabsorptive  related  components.
CASE  DESCRIPTION:  We  report  the case  of  a 60-year-old  woman  whose  past  medical  history  included  mor-
bid obesity,  hypertension  and Scopinaro  biliopancreatic  diversion  (BPD)  with  duodenal  switch  in 1998.
In  2015,  she  attended  the emergency  department  hypotensive  with  bad  general  condition  and  reporting
chronic  constitutional  symptoms.  A  wide  variety  of  tests  were  performed  including  endoscopic  studies
as her  symptoms  were  not immediately  correlated  with  the BPD  surgery.  Finally,  she was  diagnosed  from
gastrojejunal  stricture  which  caused  her severe  malnutrition.  The  patient  underwent  successful  surgical
management.
DISCUSSION:  BPD  is one  of the  most  effective  surgical  procedures  for  obesity,  with  an  overall  5-year  loss  of
excess  body  weight  higher  than  72%.  Nonetheless,  it is associated  with  long-term  complications  such  as
protein  malnutrition  and  vitamin  deﬁciencies  due  to malabsorption.  Being  surgically  challenging,  with
high  risk  of  nutritional  complications  and  lifelong  needed  for the  follow-up,  BPD is  rarely  performed
nowadays.
CONCLUSIONS:  Bariatric  Surgery  is a well-known  effective  therapeutic  measure  to improve  obesity  and
cardiovascular  related  disease.  However,  this  case  highlights  the  importance  of  robust  multidisciplinary
lifelong  surgical  and  medical  follow-up  in  all BPD  patients.  BPD  complications  can  be  minimised  and
recognised  early  with patient  and healthcare  staff education  on  the  importance  of lifetime  follow-up  and
adherence  to dietary  and  supplement  regimes.
©  2018  Published  by Elsevier  Ltd on  behalf  of  IJS Publishing  Group  Ltd.  This  is  an  open  access  article
he CCunder  t
. Introduction
Bariatric surgery provides excellent outcomes in terms of weight
oss and amelioration of associated metabolic syndrome comor-
idities such as type 2 diabetes, dyslipidaemia and hypertension
1,2]. However, it also carries certain morbidity risk. This work has
een reported in line with the SCARE criteria [3].∗ Corresponding author at: Department of Investigative Medicine, Division of
iabetes, Endocrinology and Metabolism, Imperial College London, 6th Floor, Com-
onwealth Building, Du Cane Road, London, W12  0HS, UK.
E-mail address: b.pevida@imperial.ac.uk (B. Pérez-Pevida).
ttps://doi.org/10.1016/j.ijscr.2018.02.040
210-2612/© 2018 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd. This i
rg/licenses/by-nc-nd/4.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
2. Case report
We  report the case of a 60-year-old woman who presented
to our institution, in January 2015. She gave 6 months his-
tory of vomiting (daily over the preceding three weeks), general
malaise, anorexia, dizziness, severe back pain and weight loss
of approximately 6 kg. Her past medical history included mor-
bid obesity and hypertension, Scopinaro biliopancreatic diversion
(BPD) with duodenal switch in 1998 (her follow up ceased in
2010 when patient stopped attending appointments), secondary
hyperparathyroidism. She was a non-smoker. Her regular medi-
cations included a proton pump inhibitor, multivitamin and iron
supplements, calcium, vitamin D, pain killers and an angiotensin-
converting enzyme inhibitor. Three months prior to this admission
she had already been diagnosed with iron deﬁciency anaemia. Gas-
troscopy and CT scan were normal at that time.
s an open access article under the CC BY-NC-ND license (http://creativecommons.
 –  O
al of S
b
a
a
B
a
g
(
t
t
m
i
p
t
t
n
a
t
t
l
b
a
G
t
t
w
t
F
nCASE  REPORT
B. Pérez-Pevida et al. / International Journ
On examination, she was dehydrated, pale, had thin hair and
rittle nails, coated tongue, multiple haematomas and gener-
lised oedema. She was hypotensive (85/40 mmHg), tachycardic
nd apyrexial. Her weight was 66 kg with BMI  of 26.4 kg/m2.
lood tests revealed hypoalbuminemia, microcytic/hypochromic
naemia with low ferritin level, deranged clotting, normal plasma
lucose, creatinine 1.4 mg/dL (124 umol/L), uric acid 8.8 mg/dL
523 umol/L), raised C-reactive protein. Liver, renal, thyroid func-
ion and adrenal axis tests, procalcitonin, rheumatoid factor and
umour markers were all normal. She was diagnosed of severe
alnutrition secondary to BPD and was admitted for further
nvestigations. CT-scans excluded any anatomical abnormalities,
ulmonary embolism or active bleeding. MRI  showed multiple ver-
ebral osteoporotic fractures. Echocardiogram was  normal.
Patient was given a trial of enteral nutrition via a nasogas-
ric but it was not tolerated due to recurrent vomiting. Parenteral
utrition was therefore administered. Concomitantly, degree of
naemia deteriorated despite intravenous iron supplementation,
herefore a diagnostic gastroscopy was performed. A tight anas-
omotic stenosis with coexisting ulceration at gastrojejunostomy
evel was diagnosed and neither the scope or a guidewire could not
e passed through on 2 separate attempts (Fig. 1). Biopsy of the
rea conﬁrmed benign inﬂammatory tissue.
Small bowel follow-through study was performed with
astrograﬁn
®
administered orally and no contrast passage beyond
®
he gastric pouch was seen. When Gastrograﬁn was  given through
he nasojejunal tube, normal contrast passage through the jejunum
as demonstrated (Fig. 2). Based on the ﬁndings above, an obstruc-
ion at gastrojejunostomy level was diagnosed. Therefore, patient
Fig. 1. Gastroscopy (A) Gastrojejunal anastomosis with ulceration. (B) Gu
ig. 2. Small bowel follows through (A) Gastrograﬁn® given orally ﬁlls the gastric pouc
asojejunal tube passes into jejunum.PEN  ACCESS
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was referred to the surgical team and a resection of stenosed
gastrojejunostomy with refashioning of alimentary Roux limb
was performed. The histopathology results of the resected gas-
trojejunostomy conﬁrmed chronic inﬂammation, oedema and
submucosal ﬁbrosis. Patient had uneventful postoperative recov-
ery, tolerated oral intake well and was discharged home after
70 days with supplementary oral nutrition (Diben Drink
®
), multi-
vitamin and mineral supplementation. Three months after surgery,
her weight was stable (67 kg, BMI  26.8 kg/m2), anaemia has
resolved and nutritional status improved.
3. Discussion
Bariatric surgery is treatment of choice for patients present-
ing with severe obesity and associated comorbidities [1,2,4].
Roux-en-Y gastric bypass (RYGB) and BPD result in good weight
loss and remission of many metabolic syndrome comorbidities
[1,5–7]. These effects are thought to be mediated by enhanced
gut hormones secretion (glucagon-like peptide 1, peptide YY and
oxyntomodulin), bile acids signalling, reduced intestinal glucose
transport via SGLT1 and circulating branched-chain amino acids
and changes in gut microbiome, leading to improved early insulin
secretion and sensitivity, and increased satiety [8,9]. However, due
to the limited food intake and/or malabsorption, nutritional deﬁ-
ciencies are not uncommon. BPD, ﬁrst described by Scopinaro, has
been performed over the last 25 years and results in effective
and sustained long-term weight loss [5,10]. It involves forma-
tion of a horizontal partial gastrectomy, leaving a gastric pouch
of 200–500 mls  in volume, anastomosing it to 250 cm alimentary
ide wire not passing the stricture during an attempt of dilatation.
h but does not pass to the small intestine. (B) Gastrograﬁn® administered via the
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Roux) limb which is then anastomosed to the long biliopancreatic
imb 50 cm proximal to the ileocecal valve, resulting in a very short
ommon channel. It is one of the most effective surgical procedures
or obesity, with an overall 5-year loss of excess body weight higher
han 72% [1,6,7]. Nonetheless, it is associated with long-term com-
lications such as protein malnutrition and vitamin deﬁciencies
ue to malabsorption [5,11,12], especially in patients who  are not
onitored closely. Protein malnutrition can occur in 7.7–11.9% BPD
atients and when gastric pouch is smaller than 200 mls  – even in
7.8% [11]. This risk can be minimised by adapting size of the gas-
ric pouch and length of the common limb (increasing it from 50
o 100 cm). Anatomical late complications of the BPD are reported
ess frequently. Scopinaro describes 1,2% of intestinal obstruction
ate and 11.9% protein malnutrition rate in his large series with a
ollow-up of 18 years. Despite regular use of supplements, up to 94%
f the patients may  present with vitamin (especially fat-soluble)
nd mineral deﬁciencies [12,13]. Iron deﬁciency anaemia occur in
pproximately 60% of patients undergoing BPD and is caused by
iminished secretion of stomach acids and the exclusion of the duo-
enum and proximal jejunum. Calcium deﬁciency occurs due to
xclusion of the duodenum and causes decreased bone mineraliza-
ion in one third of the BPD patients. Being surgically challenging,
ith high risk of nutritional complications and lifelong needed for
he follow-up, BPD is rarely performed nowadays.
. Conclusion
This patient presented 17 years after BPD hence her symptoms
ere not immediately correlated with the surgery. She had most
ikely developed an anastomotic ulcer which caused a stricture
nd subsequently obstructed the gastrojejunostomy (however, its
etiology could not be established). Robust multidisciplinary life-
ong surgical and medical follow-up should be offered to all BPD
atients. BPD complications can be minimised and recognised early
ith patient and healthcare staff education on the importance
f lifetime follow-up and adherence to dietary and supplement
egimes.
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